just proving Myco's point

Myco also has novel cell-based assays. In one approach Myco has engineered yeast, Aspergillus and Candida cells so the recombinant organisms visually report the desired activity of a potential drug. This Differential Output Test (DOT) permits rapid design and implementation of high-throughput screens.

In addition to its antifungal programs, Myco is working in bacterial infection, immunosuppression and cancer...